Four patients succumbed to PBL in a relatively short period of time.
2
Several distinctive cytological features were observed in PBLs of the different subgroups.
3
Conclusion: PBL can be successfully treated with aggressive chemotherapy followed by RT.
4
We investigated the clinicopathologic characteristics of six cases of PBL in Koreans.
5
The students felt that PBL provided a higher ability for intellectual stimulation.
Uso de plasmablastic lymphoma en inglés
1
CAR-T and immunocheckpoint inhibitors showed treatment effect for the patients with refractory and relapsed plasmablasticlymphoma.
2
However, plasmablasticlymphoma is listed in the World Health Organization (WHO) classification as a variant of diffuse large B-cell lymphoma.
3
These results do not support the suggestion in the WHO classification that plasmablasticlymphoma is a variant of diffuse large B-cell lymphoma.
4
Plasmablasticlymphoma has been seen in clinical settings outside those initially reported and has been shown to demonstrate a variety of morphologic patterns.
5
Plasmablasticlymphoma (PBL) is an uncommon, clinically aggressive, Epstein-Barr virus-driven B-cell lymphoma that was initially described in tumors of relatively young human immunodeficiency virus-positive men.